Prominent regression of corneal crystalline deposits in multiple myeloma after treatment with proteasome inhibitor
- 124 Downloads
All authors contributed to patient management and to the writing of the report.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Written informed consent to publish personal information and case details has been obtained from the patient.
- 3.Kourelis TV, Nasr SH, Dispenzieri A, Kumar SK, Gertz MA, Fervenza FC, Buadi FK, Lacy MQ, Erickson SB, Cosio FG, Kapoor P, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Gonsalves W, Lorenz EC, Zand L, Kyle RA, Leung N (2016) Outcomes of patients with renal monoclonal immunoglobulin deposition disease. Am J Hematol 91:1123–1128CrossRefPubMedGoogle Scholar
- 4.Reece DE, Hegenbart U, Sanchorawala V, Merlini G, Palladini G, Blade J, Fermand JP, Hassoun H, Heffner L, Kukreti V, Vescio RA, Pei L, Enny C, Esseltine DL, van de Velde H, Cakana A, Comenzo RL (2014) Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis. Blood 124:2498–2506CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Terpos E, Kleber M, Engelhardt M, Zweegman S, Gay F, Kastritis E, van de Donk NWCJ, Bruno B, Sezer O, Broijl A, Bringhen S, Beksac M, Larocca A, Hajek R, Musto P, Johnsen HE, Morabito F, Ludwig H, Cavo M, Einsele H, Sonneveld P, Dimopoulos MA, Palumbo A, on behalf of the European Myeloma Network (2015) European myeloma network guidelines for the management of multiple myeloma-related complications. Haematologica 100:1254–1266CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Houben N, Foets B (2006) Confocal microscopy in multiple myeloma associated crystalline keratopathy: case report. Bull Soc Belg Ophthalmol 300:13–17Google Scholar